C. Meier

First name
C.
Middle name
R.
Last name
Meier
Gasse, C., Hollowell, J., Meier, C. R., & Haefeli, W. E. (2005). Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin. Thromb Haemost. http://doi.org/10.1160/th05-03-0166
Fischer, L. M., Schlienger, R. G., Matter, C. M., Jick, H., & Meier, C. R. (2005). Current use of nonsteroidal antiinflammatory drugs and the risk of acute myocardial infarction. Pharmacotherapy.
Schlienger, R. G., Fedson, D. S., Jick, S. S., Jick, H., & Meier, C. R. (2007). Statins and the risk of pneumonia: a population-based, nested case-control study. Pharmacotherapy. http://doi.org/10.1592/phco.27.3.325
Becker, C., Brobert, G. P., Almqvist, P. M., Johansson, S., Jick, S. S., & Meier, C. R. (2007). Migraine and the risk of stroke, TIA, or death in the UK (CME). Headache. http://doi.org/10.1111/j.1526-4610.2007.00937.x
Becker, C., Jick, S. S., & Meier, C. R. (2008). Use of statins and the risk of Parkinson\textquoterights disease: a retrospective case-control study in the UK. Drug Saf.
Becker, C., Brobert, G. P., Almqvist, P. M., Johansson, S., Jick, S. S., & Meier, C. R. (2008). Migraine incidence, comorbidity and health resource utilization in the UK. Cephalalgia. http://doi.org/10.1111/j.1468-2982.2007.01469.x
Brauchli, Y. B., Jick, S. S., & Meier, C. R. (2008). Psoriasis and the risk of incident diabetes mellitus: a population-based study. Br J Dermatol. http://doi.org/10.1111/j.1365-2133.2008.08814.x
Becker, C., Brobert, G. P., Almqvist, P. M., Johansson, S., Jick, S. S., & Meier, C. R. (2008). The risk of newly diagnosed asthma in migraineurs with or without previous triptan prescriptions. Headache. http://doi.org/10.1111/j.1526-4610.2007.01030.x
Meier, C., Kraenzlin, M. E., Bodmer, M., Jick, S. S., Jick, H., & Meier, C. R. (2008). Use of thiazolidinediones and fracture risk. Arch Intern Med. http://doi.org/10.1001/archinte.168.8.820
Schneider, C., Jick, S. S., & Meier, C. R. (2009). Risk of cardiovascular outcomes in users of estradiol/dydrogesterone or other HRT preparations. Climacteric. http://doi.org/10.1080/13697130902780853